Drugs / Infudopa
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03419806 | Feb 2018 → Mar 2020 | Parkinson disease | Vastra Gotaland Region | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Infudopa | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03419806 ↗ |
| Route | Intravenous | “administered as a morning rapid i.v. constant rate administration followed by continuous i.v. infusion.” NCT03419806 ↗ |